Outcome Of Treatment Of Prostate Cancer at Sohag University Hospital Between 2017 to 2021
试验速览
- 阶段
- 不适用
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- overall survival
研究概览
简要总结
Worldwide, prostate cancer is the most commonly diagnosed male cancer and the fourth leading cause of cancer death in men. Risk stratification is according to cancer stage, Gleason score, and PSA level .
Definitive treatment of localized disease ( low and favorable intermediate risk) includes watchful waiting , active surveillance , radiation therapy , radical prostatectomy and cryotherapy .Primary treatment of unfavorable intermediate risk , high risk localized disease and locally advanced prostate cancer , includes both radical prostatectomy (RP) and EBRT + long-term androgen deprivation therapy (ADT) .Treatment options of metastatic prostate cancer include pain medications, bisphosphonates, hormonal treatment, chemotherapy, radiotherapy, immunotherapy, focused radiation, and other targeted therapies .
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Patients at age of 18 years old and above.
- •All stages and grades of prostate cancer.
- •Epithelial types of prostate cancer.
排除标准
- •Age below 18 years old.
- •Presence of other malignancies.
结局指标
主要结局
overall survival
时间窗: 6 months
Overall survival defined as the time from the date of diagnosis to the last date seen .
progression free survival
时间窗: 6 months
Progression-free survival defined as the length of time during and after the treatment of cancer that a patient lives with the disease but it does not get worse.
disease free survival
时间窗: 6 months
Disease free survival defined as the time from the end of treatment to the date of first relapse .
次要结局
未报告次要终点
研究者
Aya Ahmed Sayed
resident doctor at oncology department at faculty of medicine sohag university hospital
Sohag University